Question 1

How many shares of BTAI does ADAGE CAPITAL PARTNERS GP, L.L.C. own?

Accepted Answer

ADAGE CAPITAL PARTNERS GP, L.L.C. previously held 0 shares of BTAI (BIOXCEL THERAPEUTICS INC) before exiting the position in 2024-Q1.

Question 2

What is ADAGE CAPITAL PARTNERS GP, L.L.C.'s BTAI position worth?

Accepted Answer

ADAGE CAPITAL PARTNERS GP, L.L.C.'s BTAI position was last reported at $0 in 2024-Q1 before the exit.

Question 3

Is ADAGE CAPITAL PARTNERS GP, L.L.C. buying or selling BTAI?

Accepted Answer

In 2024-Q1, ADAGE CAPITAL PARTNERS GP, L.L.C. exited their BTAI position entirely (-100.0% change in shares).

Question 4

When did ADAGE CAPITAL PARTNERS GP, L.L.C. first buy BTAI?

Accepted Answer

Based on available 13F filings, ADAGE CAPITAL PARTNERS GP, L.L.C. first reported a position in BTAI in 2022-Q4. They have held the position across 6 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$45.12	0
2023-Q4	Increased	465,381	+132.7%	$1.4M	0.0%	$47.20	41
2023-Q3	Decreased	200,000	-89.8%	$506,000	0.0%	$40.48	0
2023-Q2	Decreased	2M	-6.2%	$13M	0.0%	$102.24	0
2023-Q1	Increased	2.1M	+137.9%	$38.8M	0.1%	$297.60	47
2022-Q4	New	875,000	-	$18.8M	0.0%	$343.68	39

BTAI6 quarters

BTAI
6 quarters